HYPERLIPIDEMIAS
Clinical trials for HYPERLIPIDEMIAS explained in plain language.
Never miss a new study
Get alerted when new HYPERLIPIDEMIAS trials appear
Sign up with your email to follow new studies for HYPERLIPIDEMIAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New program aims to boost heart health and cut stress in black men
Disease control Recruiting nowThis study tests a 24-week program called Black Impact to improve heart health and reduce stress in Black men. About 340 Black men with below-ideal heart health will either join the program right away or be placed on a waitlist. The program includes weekly exercise, health educat…
Matched conditions: HYPERLIPIDEMIAS
Phase: NA • Sponsor: Ohio State University • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New program aims to lower heart risks in High-Risk patients
Disease control Recruiting nowThis study tests a program to help people with high blood pressure and high cholesterol lower their risk of heart disease. About 1,980 adults from Penn Medicine primary care will be assigned to either the program or usual care. The program uses tools and behavior change support t…
Matched conditions: HYPERLIPIDEMIAS
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
Scientists investigate Protein's role in kidney disease
Knowledge-focused Recruiting nowThis study looks at whether a protein called PCSK9 is higher in people with nephrotic syndrome (a kidney condition causing protein leakage) and if it relates to kidney damage. Researchers will compare blood and kidney tissue samples from 75 participants—those with the condition a…
Matched conditions: HYPERLIPIDEMIAS
Sponsor: Kolding Sygehus • Aim: Knowledge-focused
Last updated May 26, 2026 03:11 UTC
-
New cholesterol drug tested in people with kidney problems
Knowledge-focused Recruiting nowThis study looks at how a new cholesterol-lowering tablet, HRS-1301, behaves in people with mild, moderate, or severe kidney problems compared to those with healthy kidneys. About 36 adults aged 18 to 65 will take a single dose, and researchers will measure drug levels and safety…
Matched conditions: HYPERLIPIDEMIAS
Phase: PHASE1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated May 20, 2026 11:54 UTC
-
68,000-Patient study tests if fighting racism lowers blood pressure
Knowledge-focused Recruiting nowThis study looks at whether screening for social needs (like housing or food) with a focus on antiracism can help reduce chronic diseases such as high blood pressure, diabetes, and asthma. About 68,000 adults and children in primary care will take part. The goal is to see if this…
Matched conditions: HYPERLIPIDEMIAS
Phase: NA • Sponsor: University of Massachusetts, Worcester • Aim: Knowledge-focused
Last updated May 18, 2026 12:06 UTC
-
Brain scan study aims to uncover hidden clues of dementia risk
Knowledge-focused Recruiting nowThis study follows 50 people who have had a stroke and at least one risk factor like high blood pressure or diabetes. Researchers use repeated MRI scans over 15 months to watch how small blood vessel damage in the brain gets worse. The goal is to learn more about how this damage …
Matched conditions: HYPERLIPIDEMIAS
Sponsor: Johns Hopkins University • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC